Ac. Jones et al., Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis, HUM GENET, 106(6), 2000, pp. 663-668
Tuberous sclerosis (TSC) is an autosomal dominant disorder characterised by
the development of hamartomas in multiple tissues and organs. TSC exhibits
locus heterogeneity with genes at 9q34 (TSC1) and 16p13.3 (TSC2) that have
21 and 41 coding exons, respectively. The mutational spectrum at both loci
is wide and previous studies have shown that 60%-70% of cases are sporadic
and represent new mutations. We have formatted denaturing high performance
liquid chromatography (DHPLC) for rapid screening of all coding exons of T
SC1 and TSC2. DHPLC analysis detected likely disease-causing mutations in 1
03 of 150 unrelated cases (68%), compared with 92/150 (61%) and 87/150 (58%
) fdr single-strand conformation polymorphism analysis (SSCP) and conventio
nal heteroduplex analysis (HA), respectively. Capital, consumable and labou
r costs were determined for each exon screening procedure. Estimated costs
per patient sample depended on throughput, particularly for DHPLC, where a
high proportion of costs are fixed, and were pound 257, pound 216 and pound
242 for DHPLC, SSCP and HA, respectively, assuming a throughput of 252 sam
ples per year, or pound 354, pound 233 and pound 259, assuming a throughput
of 126 samples per year. DHPLC had the advantages of increased sensitivity
and reduced labour costs when compared with more traditional approaches to
exon screening but, unless expensive DHPLC equipment is being efficiently
utilised for a very high proportion of the time available, overall costs ar
e slightly higher.